UPDATE: Teva Pharmaceutical Posts Upbeat Q4 Earnings

Teva Pharmaceutical Industries TEVA reported better-than-expected fourth-quarter earnings. Teva's quarterly earnings, excluding one-time items, came in at $1.42 per share, versus $1.32 per share. Its revenue gained 3% to $5.43 billion. However, analysts were expecting earnings of $1.40 per on revenue of $5.19 billion. Teva shares gained 0.12% to $45.45 in pre-market trading.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsprofit
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!